Pharmacological characterization of the zebrafish Hrh2a histamine H2 receptor.

The zebrafish, Danio rerio , is a widely adopted in vivo model that conserves organs such as the liver, kidney, stomach, and brain, being, therefore, suitable for studying human diseases, drug discovery and toxicology. The brain aminergic systems are also conserved and the histamine H 1 , H 2 and H 3 receptors were previously cloned and identified in the zebrafish brain. Genome studies identified another putative H 2 receptor (Hrh2) with ∼50% sequence identity with H 2 receptor orthologs. In this study, we recombinantly expressed both zebrafish H 2 receptor paralogs (hrh2a and hrh2b) and compared their pharmacology with the human H 2 receptor ortholog. Our results showed that both zebrafish receptors conserve all the class A GPCR motifs. However, in contrast with the Hrh2a paralog, the Hrh2b does not possess all the amino acid residues shown to participate in histamine binding. The zebrafish Hrh2a receptor displays high affinity for [3H]-tiotidine with a binding profile for H 2 receptor ligands similar to that of the human H 2 receptor. The zebrafish Hrh2a receptor couples to Gα S and Gα q/11 proteins, resulting in cAMP accumulation and activation of several reporter genes linked to the Gα q/11 pathway. Additionally, this receptor shows high constitutive activity, with histamine potency in the low nanomolar range for cAMP accumulation and the micromolar range for the activation of the NFAT response element. Moreover, dimaprit and amthamine seem to preferentially activate Gα S over Gα q/11 proteins via the zebrafish Hrh2a receptor. These results can contribute to clarifying the functional roles of the H 2 receptor in zebrafish. [ABSTRACT FROM AUTHOR]